KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q1 2021 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA) Q1 2021 Earnings Conference Call May 05, 2021, 08:00 ET Company Participants Niranjan Kameswaran - SVP, Strategy Mark Iwicki - Chairman, President & CEO Todd Bazemore - COO Mary Reumuth - CFO & Treasurer Conference Call Participants Andreas Argyrides - Wedbush Securities Christopher Neyor - JPMorgan Chase & Co. François Brisebois - Oppenheimer Tazeen Ahmad - Bank of America Merrill Lynch Yi Chen - H.C. Wainwright & Co. Timothy Chiang - Northland Capital Markets Kelly Shi - Jefferies Presentation Operator Good morning and welcome to Kala Pharmaceuticals' First Quarter 2021 Financial Results Conference Call. [Operator Instructions]. As a reminder, this call is being recorded. I would now like to turn the call over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals. Please proceed. Niranjan Kameswaran Thank you, operator and thank you all for participating in today's call. Joining me from the company are
For further details see:
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2021 Results - Earnings Call Transcript